Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC
- PMID: 11897681
- DOI: 10.1210/endo.143.4.8739
Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC
Abstract
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a potentiator of glucose-induced insulin secretion. PACAP binds to a PACAP-specific receptor (PAC1) and to VPAC receptors (VPAC1 and VPAC2), which share high affinity for vasoactive intestinal polypeptide (VIP). In the present study, the molecular expression of PACAP receptor isoforms and the signaling pathways involved in the insulin secretory effect of PACAP were investigated in isolated rat and mouse pancreatic islets. mRNA encoding PAC1-short, -hop, and -very short variants, as well as VPAC1 and VPAC2, were expressed in pancreatic islets. PACAP and VIP were equipotent in potentiating glucose-induced insulin release. Both peptides were also equipotent in increasing cAMP production, but PACAP was more efficient than VIP. Unlike carbachol, PACAP and VIP had no effect on inositol phosphate production. In the PAC1-deficient mouse, the insulinotropic effect of PACAP was reduced, and its differential effect on cAMP production was abolished, whereas the effects of VIP remained unchanged. These results clearly show that the insulinotropic effect of PACAP involved both VPAC and PAC1. The PAC1 variants expressed in rat and mouse pancreatic islets seem to be coupled to adenylate cyclase but not to PLC.
Similar articles
-
A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.Endocrinology. 1999 Mar;140(3):1285-93. doi: 10.1210/endo.140.3.6576. Endocrinology. 1999. PMID: 10067855
-
Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.Int J Mol Med. 2002 Mar;9(3):233-43. Int J Mol Med. 2002. PMID: 11836629
-
VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.Endocrinology. 2005 Feb;146(2):744-50. doi: 10.1210/en.2004-0504. Epub 2004 Oct 28. Endocrinology. 2005. PMID: 15514088
-
PACAP/VIP receptors in pancreatic beta-cells: their roles in insulin secretion.Ann N Y Acad Sci. 1996 Dec 26;805:44-51; discussion 52-3. doi: 10.1111/j.1749-6632.1996.tb17472.x. Ann N Y Acad Sci. 1996. PMID: 8993392 Review.
-
Role of VIP and PACAP in islet function.Peptides. 2007 Sep;28(9):1805-13. doi: 10.1016/j.peptides.2007.04.024. Epub 2007 May 6. Peptides. 2007. PMID: 17559974 Review.
Cited by
-
Intra-islet PACAP protects pancreatic β-cells against glucotoxicity and lipotoxicity.J Mol Neurosci. 2010 Nov;42(3):404-10. doi: 10.1007/s12031-010-9383-4. Epub 2010 May 12. J Mol Neurosci. 2010. PMID: 20461496
-
Pituitary adenylate cyclase activating peptide (PACAP) participates in adipogenesis by activating ERK signaling pathway.PLoS One. 2013 Sep 9;8(9):e72607. doi: 10.1371/journal.pone.0072607. eCollection 2013. PLoS One. 2013. PMID: 24039785 Free PMC article.
-
Pituitary adenylate cyclase-activating peptide receptor 1 mediates anti-inflammatory effects in allergic airway inflammation in mice.Clin Exp Allergy. 2011 Apr;41(4):592-601. doi: 10.1111/j.1365-2222.2010.03636.x. Epub 2010 Nov 9. Clin Exp Allergy. 2011. PMID: 21059121 Free PMC article.
-
Convergent phosphomodulation of the major neuronal dendritic potassium channel Kv4.2 by pituitary adenylate cyclase-activating polypeptide.Neuropharmacology. 2016 Feb;101:291-308. doi: 10.1016/j.neuropharm.2015.10.006. Epub 2015 Oct 9. Neuropharmacology. 2016. PMID: 26456351 Free PMC article.
-
The ellagitannin metabolite urolithin C is a glucose-dependent regulator of insulin secretion through activation of L-type calcium channels.Br J Pharmacol. 2019 Oct;176(20):4065-4078. doi: 10.1111/bph.14821. Epub 2019 Oct 10. Br J Pharmacol. 2019. PMID: 31378934 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical